Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives
International Journal of Immunopathology and Pharmacology · 2024-01 · 38
DOI: 10.1177/03946320241289013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Immunopathology and Pharmacology, online erschienen am 04.10.2024. Verfasst von Snežana M Jovičić. Beteiligte Einrichtung: Department of Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Cholinesterase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Enzyme Che plays an essential role in cholinergic and non-cholinergic functions. It is present in the fertilized/unfertilized eggs and sperm of different species. Inclusion criteria for data collection from electronic databases NCBI and Google Scholar are enzyme AChE/BChE, cholinergic therapy, genomic organization and gene transcription, enzyme structure, biogenesis, transport, processing and localization, molecular signaling and biological function, polymorphism and influencing factors. Enzyme Che acts as a signaling receptor during hematopoiesis, protein adhesion, amyloid fiber formation, neurite outgrowth, bone development, and maturation, explaining the activity out of synaptic neurotransmission. Polymorphism in the Che genes correlates to various diseases and diverse drug responses. In particular, change accompanies cancer, neurodegenerative, and cardiovascular disease. Literature knowledge indicates the importance of Che inhibitors that influence biochemical and molecular pathways in disease treatment, genomic organization, gene transcription, structure, biogenesis, transport, processing, and localization of Che enzyme. Enzyme Che polymorphism changes indicate the possibility of efficient and new inhibitor drug target mechanisms in diverse research areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
ORCID-Profile: Snežana M Jovičić
Zitieren
APA
Jovičić, S. M. (2024). Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives. International Journal of Immunopathology and Pharmacology, 38. https://doi.org/10.1177/03946320241289013
Vancouver
Jovičić SM. Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives. International Journal of Immunopathology and Pharmacology. 2024;38. doi:10.1177/03946320241289013
BibTeX
@article{Jovii2024,
author = {Jovičić, Snežana M},
title = {Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2024},
volume = {38},
doi = {10.1177/03946320241289013}
}
EUVIMED